NITISINONE
| Brand name | ORFADIN |
|---|---|
| Active ingredient | NITISINONE |
| Strength | 5MG |
| Dosage form | CAPSULE |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | January 2002 |
| Marketing status | RX |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.